Back | Next |
home / stock / okyo / okyo message board
Subject | By | Source | When |
---|---|---|---|
Loaded | Count Crypto | investorshub | 10/04/2023 7:40:35 PM |
$OKYO MomentumIts trading last up | Count Crypto | investorshub | 10/04/2023 7:40:30 PM |
Heading to $3 | Sirpeter | investorshub | 10/04/2023 7:14:13 PM |
Looking great! | Ryguy008 | investorshub | 10/04/2023 6:40:53 PM |
The now | Sirpeter | investorshub | 10/04/2023 5:59:35 PM |
$OKYO Price trading last up | Sirpeter | investorshub | 10/04/2023 5:37:23 PM |
First half of the week price action is | mfayman | investorshub | 10/04/2023 3:44:27 PM |
$OKYO and the shorts continue | Count Crypto | investorshub | 10/04/2023 3:20:28 PM |
$OKYO Have a look at this | Count Crypto | investorshub | 10/04/2023 2:33:53 PM |
Another big volume day like yesterday we're moving $$ | mfayman | investorshub | 10/04/2023 12:06:42 PM |
Once we break 2.50 clear skies to 3$ imo | mfayman | investorshub | 10/04/2023 12:03:29 PM |
Were primed, loving the activity here last couple days! | mfayman | investorshub | 10/04/2023 11:59:29 AM |
Get some | Count Crypto | investorshub | 10/04/2023 11:29:27 AM |
short data if anyone is interested | Ryguy008 | investorshub | 10/04/2023 10:27:31 AM |
$OKYO Price now up | mfayman | investorshub | 10/04/2023 8:54:40 AM |
$OKYO short squeeze article | Pisd | investorshub | 10/04/2023 2:09:07 AM |
Seeing that next leg up here $ | mfayman | investorshub | 10/04/2023 1:26:38 AM |
Killer volume today! | mfayman | investorshub | 10/04/2023 1:26:08 AM |
Hey now | Count Crypto | investorshub | 10/03/2023 11:16:30 PM |
$OKYO and the shorts continue | Pisd | investorshub | 10/03/2023 10:32:56 PM |
News, Short Squeeze, Breakout and More Instantly...
OKYO Pharma Limited Company Name:
OKYO Stock Symbol:
NASDAQ Market:
LONDON and NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases ...
LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment disease...
LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing...